Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
APGNW was delisted on the 22nd of August, 2023.
1 hedge funds and large institutions have $1.49K invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 18 closing their positions.
94% less capital invested
Capital invested by funds: $24.6K → $1.49K (-$23.1K)
95% less funds holding
Funds holding: 19 → 1 (-18)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 18
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$5K |
| 2 |
Walleye Capital
New York
|
-$3.61K |
| 3 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2.89K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.87K |
| 5 |
SM
Skaana Management
Brooklyn,
New York
|
-$2.48K |
APGNW Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q3 2023, worth a combined $1.49K — down 94% from $24.6K a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of APGNW and 0 opened new positions — a net loss of 18 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Kepos Capital, exiting entirely with an estimated $5K sold.
- 1 institutional investor held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q3 2023, down from 19 in Q2 2023.
- Funds reported $1.49K of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q3 2023, down 94% quarter-over-quarter.
- 0 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q3 2023 and 18 closed out, a net change of -18 holders.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant seller in Q3 2023 was Kepos Capital, an estimated $5K sold.
Based on aggregated 13F filings for Q3 2023.